Table 6.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Pancreas Transplant Alone (PTA) Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		35	52	39	41	53	78	88	136	135	163
Tx With Follow-up Immunosuppression Info		28	28	29	31	41	57	71	116	105	131
Corticosteroids	Category Usage	0.0%	21.4%	48.3%	80.6%	97.6%	100.0%	100.0%	100.0%	98.1%	93.1%
	Steroids	0.0%	21.4%	48.3%	80.6%	97.6%	100.0%	100.0%	100.0%	98.1%	93.1%
Cyclosporine	Category Usage	89.3%	89.3%	48.3%	45.2%	48.8%	24.6%	18.3%	6.9%	7.6%	7.6%
	Cyclosporin	89.3%	89.3%	48.3%	22.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	3.6%	3.4%	9.7%	9.8%	1.8%	0.0%	0.0%	1.9%	0.0%
	Neoral	0.0%	0.0%	0.0%	29.0%	46.3%	22.8%	18.3%	6.9%	4.8%	7.6%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.0%	0.8%
Tacrolimus	Category Usage	10.7%	14.3%	69.0%	58.1%	73.2%	80.7%	91.5%	94.8%	94.3%	98.5%
	FK506	10.7%	14.3%	69.0%	58.1%	73.2%	80.7%	91.5%	94.8%	94.3%	98.5%
Antimetabolites	Category Usage	92.9%	85.7%	93.1%	96.8%	95.1%	91.2%	90.1%	91.4%	84.8%	77.1%
	Azathioprine	92.9%	85.7%	93.1%	51.6%	14.6%	12.3%	12.7%	2.6%	5.7%	2.3%
	Mycophenolate mofetil	0.0%	0.0%	3.4%	61.3%	90.2%	80.7%	84.5%	91.4%	81.9%	74.8%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	17.2%	24.8%	15.3%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	17.2%	24.8%	15.3%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.